{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:41:50Z","timestamp":1778262110925,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,4]]},"DOI":"10.7759\/cureus.16882","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T16:00:30Z","timestamp":1628092830000},"source":"Crossref","is-referenced-by-count":2,"title":["Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma: Diagnostic Perils and Pitfalls, an Underrecognized Entity"],"prefix":"10.7759","author":[{"given":"Zachariah","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1200849","article-title":"Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system","volume":"14","author":"Iwahara T","year":"1997","unstructured":"Iwahara T, Fujimoto J, Wen D, et al.. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene. 1997, 14:439-49. 10.1038\/sj.onc.1200849","journal-title":"Oncogene"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178416","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature","volume":"12","author":"Jiang XN","year":"2017","unstructured":"Jiang XN, Yu BH, Wang WG, Zhou XY, Li XQ. Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature. PLoS One. 2017, 12:e0178416. 10.1371\/journal.pone.0178416","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V89.5.1483","article-title":"A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation","volume":"89","author":"Delsol G","year":"1997","unstructured":"Delsol G, Lamant L, Mariam\u00e9 B, et al.. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood. 1997, 89:1483-90.","journal-title":"Blood"},{"key":"ref4","article-title":"ALK-positive large B cell lymphoma. In: WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"Campo E","year":"2017","unstructured":"Campo E, Gascoyne RD. ALK-positive large B cell lymphoma. In: WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC. Swerdlow SH, Campo E, Harris NL, et al. (ed): International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France; 2017. Revised 4th Edition:319-20."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.12.019","article-title":"Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24","volume":"38","author":"Stachurski D","year":"2007","unstructured":"Stachurski D, Miron PM, Al-Homsi S, Hutchinson L, Harris NL, Woda B, Wang SA. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24. Hum Pathol. 2007, 38:940-5. 10.1016\/j.humpath.2006.12.019","journal-title":"Hum Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1050","article-title":"ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma","volume":"102","author":"De Paepe P","year":"2003","unstructured":"De Paepe P, Baens M, van Krieken H, et al.. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood. 2003, 102:2638-41. 10.1182\/blood-2003-04-1050","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403921","article-title":"ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas","volume":"19","author":"Gesk S","year":"2005","unstructured":"Gesk S, Gascoyne RD, Schnitzer B, et al.. ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas. Leukemia. 2005, 19:1839-40. 10.1038\/sj.leu.2403921","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-11","article-title":"ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature","volume":"2","author":"Beltran B","year":"2009","unstructured":"Beltran B, Castillo J, Salas R, et al.. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. J Hematol Oncol. 2009, 2:11. 10.1186\/1756-8722-2-11","journal-title":"J Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1095","article-title":"ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases","volume":"102","author":"Onciu M","year":"2003","unstructured":"Onciu M, Behm FG, Downing JR, et al.. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood. 2003, 102:2642-4. 10.1182\/blood-2003-04-1095","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.06.001","article-title":"ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement","volume":"35","author":"McManus DT","year":"2004","unstructured":"McManus DT, Catherwood MA, Carey PD, Cuthbert RJ, Alexander HD. ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement. Hum Pathol. 2004, 35:1285-8. 10.1016\/j.humpath.2004.06.001","journal-title":"Hum Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000081729.40230.1F","article-title":"ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC)","volume":"16","author":"Chikatsu N","year":"2003","unstructured":"Chikatsu N, Kojima H, Suzukawa K, et al.. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod Pathol. 2003, 16:828-32. 10.1097\/01.MP.0000081729.40230.1F","journal-title":"Mod Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.5020","article-title":"Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis","volume":"27","author":"Laurent C","year":"2009","unstructured":"Laurent C, Do C, Gascoyne RD, et al.. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. J Clin Oncol. 2009, 27:4211-6. 10.1200\/JCO.2008.21.5020","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PCR.0b013e3182523054","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: a rare tumor and a challenging diagnosis","volume":"17","author":"Morgan EA","year":"2012","unstructured":"Morgan EA, Armand P, Cleary JM, Burks EJ, Rodig SJ. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a rare tumor and a challenging diagnosis. Pathol Case Rev. 2012, 17:62-8. 10.1097\/PCR.0b013e3182523054","journal-title":"Pathol Case Rev"},{"key":"ref14","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: a potential diagnostic pitfall","volume":"58","author":"Yu H","year":"2015","unstructured":"Yu H, Huang J, Sun J, Wang C, Lin M, Li H. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a potential diagnostic pitfall. Indian J Pathol Microbiol. 2015, 58:241-5.","journal-title":"Indian J Pathol Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/529572","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma","volume":"2012","author":"Morgan EA","year":"2012","unstructured":"Morgan EA, Nascimento AF. Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma. Adv Hematol. 2012, 2012:529572. 10.1155\/2012\/529572","journal-title":"Adv Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000753","article-title":"ALK-positive large B-cell lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature","volume":"41","author":"Pan Z","year":"2017","unstructured":"Pan Z, Hu S, Li M, et al.. ALK-positive large B-cell lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature. Am J Surg Pathol. 2017, 41:25-38. 10.1097\/PAS.0000000000000753","journal-title":"Am J Surg Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage KJ","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, et al.. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008, 111:5496-504. 10.1182\/blood-2008-01-134270","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1013224","article-title":"Crizotinib in anaplastic large-cell lymphoma","volume":"364","author":"Gambacorti-Passerini C","year":"2011","unstructured":"Gambacorti-Passerini C, Messa C, Pogliani EM. Crizotinib in anaplastic large-cell lymphoma. N Engl J Med. 2011, 364:775-6. 10.1056\/NEJMc1013224","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2014.0034","article-title":"Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma","volume":"12","author":"Cleary JM","year":"2014","unstructured":"Cleary JM, Rodig S, Barr PM, Shinagare AB, Clark JW, Shapiro GI, Armand P. Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma. J Natl Compr Canc Netw. 2014, 12:323-6. 10.6004\/jnccn.2014.0034","journal-title":"J Natl Compr Canc Netw"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70095-0","article-title":"Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study","volume":"14","author":"Moss\u00e9 YP","year":"2013","unstructured":"Moss\u00e9 YP, Lim MS, Voss SD, et al.. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol. 2013, 14:472-80. 10.1016\/S1470-2045(13)70095-0","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65095-anaplastic-lymphoma-kinase-positive-large-b-cell-lymphoma-diagnostic-perils-and-pitfalls-an-underrecognized-entity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:10Z","timestamp":1707507190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65095-anaplastic-lymphoma-kinase-positive-large-b-cell-lymphoma-diagnostic-perils-and-pitfalls-an-underrecognized-entity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.16882","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,4]]}}}